CN Patent

CN114599349B — 用于透皮施用芬戈莫德的透皮治疗系统

Assigned to LTS Lohmann Therapie Systeme AG · Expires 2024-04-09 · 2y expired

What this patent protects

本发明涉及用于透皮施用芬戈莫德的透皮治疗系统(TTS)。

USPTO Abstract

本发明涉及用于透皮施用芬戈莫德的透皮治疗系统(TTS)。

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: CN114599349B
Jurisdiction: CN
Classification: —
Expires: 2024-04-09
Drug substance claim: No
Drug product claim: No
Assignee: LTS Lohmann Therapie Systeme AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.